Share Capital (Tables)

12 Months Ended

Dec. 31, 2020

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares		Multiple Voting Shares			Super Voting Shares
As at January 1, 2019		43,920,131		677,230			424,513
Issuance of shares under business combinations and investments		45,571,444		—			—
Noncontrolling Interests adjustment for change in ownership		—		31,000			—
Issuance of shares for redemption of noncontrolling interest		2,498,404		—			—
Issuance of shares upon vesting of RSUs		1,165,630		—			—
Issuance of shares upon exercise of broker options		114,080		—			—
Issuance of shares for professional fees		19,875		—			—
Exchange of shares		35,710,400		(334,880	)		(22,224	)
As at December 31, 2019		128,999,964		373,350			402,289
As at January 1, 2020		128,999,964		373,350			402,289
Issuance of shares under business combinations and investments		1,752,065		—			—
Distribution of contingent consideration		2,713,463		—			—
Distribution of deferred shares		1,220,548		—			—
Issuance of shares upon exercise of options and warrants		171,813		—			—
Issuances of shares upon vesting of RSUs		923,468		—			—
Exchange of shares		42,331,900		(333,061	)		(90,258	)
As at December 31, 2020		178,113,221		40,289			312,031

Schedule of Business Acquisitions of Contingent Consideration

The following table represents the contingent shares issued during the year ended December 31, 2020 in relation to each acquisition:

Contingent Shares Issued
			December 31, 2020
Transaction	Date of Transaction		Units		Value
Advanced Grow Labs, LLC		February 12, 2019		1,396,533	$	11,544,855
For Success Holding Company		February 21, 2019		779,690		6,686,432
Integral Associates, LLC		June 5, 2019		537,240		4,654,526
				2,713,463	$	22,885,813

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:

	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Balance as at December 31, 2019		3,839,017			13.21		5.57	$	218,234
Granted		2,604,511			10.36
Exercised		(165,872	)		12.72
Forfeited		(613,250	)		13.27
Balance as at December 31, 2020		5,664,406			11.91		4.39	$	85,408,034
Vested		1,749,365			13.37
Exercisable at December 31, 2020		1,532,282			13.22		5.07	$	21,590,351

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options at the grant dates during the years ended December 31, 2020 and 2019 using the following ranges of assumptions:

	Year Ended December 31,
	2020		2019
Risk-free interest rate		0.31% – 1.37%		1.18% – 1.84%
Expected dividend yield		0%		0%
Expected volatility		80%		80% – 100%
Expected option life		3 – 5 years		3 – 5 years

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of nonvested RSU awards as of December 31, 2020 and 2019 and the changes during the year ended December 31, 2020:

	Number of Shares			Weighted Average Grant Date Fair Value (C$)
Nonvested Shares at December 31, 2019		1,399,762			9.30
Granted		286,880			13.90
Forfeited		(73,834	)		15.85
Vested		(923,468	)		15.21
Nonvested Shares at December 31, 2020		689,340			16.77

Summary of Deferred Shares Held By The Company

The following table summarizes the deferred shares held by the Company as of December 31, 2020 and 2019:

Deferred Shares Outstanding
			December 31, 2020				December 31, 2019
Transaction	Date of Transaction		Units		Value		Units		Value
Advanced Grow Labs, LLC		February 12, 2019		—	$	—		472,500	$	5,380,000
For Success Holding Company		February 21, 2019		147,095		1,835,330		793,448		9,900,000
Rise Canton		May 15, 2019		—		—		101,695		1,307,798
Southern CT Wellness and Healing		December 18, 2020		32,205		751,987		—		—
				179,300	$	2,587,317		1,367,643	$	16,587,798

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value and intrinsic value of options exercised for the years ended December 31, 2020, 2019 and 2018:

	Year Ended December 31,
	2020		2019		2018
Weighted average grant date fair value (per share) of stock option units granted (C$)		6.58		8.06		10.85
Intrinsic value of stock option units exercised, using market price at exercise date (USD)	$	1,184,089	$	88,010	$	31,604

Restricted Stock Units

Disclosure of Share Capital [Line Items]

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the years ended December 31, 2020, 2019 and 2018 was as follows:

	For the Year Ended December 31,
	2020		2019		2018
Stock Options Expense	$	10,937,768	$	6,393,277	$	1,876,627
RSU Expense		8,398,950		11,892,100		4,748,444
Total Stock-Based Compensation Expense	$	19,336,718	$	18,285,377	$	6,625,071

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value and total fair value of RSUs vested for the years ended December 31, 2020, 2019 and 2018:

	Year Ended December 31,
	2020		2019		2018
Weighted average grant date fair value (per share) of RSUs granted (C$)		13.90		11.70		10.28
Total fair value of RSUs vested, using market price at vest date (USD)	$	9,076,673	$	13,522,284	$	—